UNLIMITED TURBO SHORT - MERCK & CO. | Market Closed - Euronext Paris 12:30:02 2024-06-27 pm EDT | ||
| 1.866 EUR | +29.49% |
|
| Current month | -16.06% | ||
| 1 month | +2.27% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 1.85 | +28.38% |
| 24-06-26 | 1.441 | -2.77% |
| 24-06-25 | 1.482 | -3.33% |
| 24-06-24 | 1.533 | -14.88% |
| 24-06-21 | 1.801 | -1.21% |
Real-time Euronext Paris
Last update June 27, 2024 at 12:30 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| HY6MB | |
| ISIN | NLBNPNL2MGX4 |
| Date issued | 2024-01-22 |
| Strike | 147.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.72 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.975 € |
|---|---|
| Lowest since issue | 1.332 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.8
USD
Average target price
142.7
USD
Spread / Average Target
+9.91%
- Stock Market
- Certificates
- HY6MB Certificat
